Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)

NCT06603597 is registered in ClinicalTrials.gov with Priyanka Sharma as lead sponsor.

NCT NCT06603597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06603597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Outcomes for HER2-positive Breast Cancer (PRO-HER2)
Lead sponsor
Priyanka Sharma
Phase
Observational
Overall status
Recruiting
Start date
September 27, 2024
Completion date
October 31, 2044
Enrollment
1,000 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

her2 + breast cancer